Imports Of Medical Devices Grow 37% In 2021-22

New Delhi : Import of medical devices to the country during the year 2021-22 has seen an increase of 36.8 per cent to $8.54 billion, with the highest growth in terms of imports registered in the category of implants. Exports of medical devices, during the period, grew by 15.4 per cent to $2.92 billion from the $2.53 billion reported in the previous year.

According to data from the ministry of chemicals and fertilisers, the imports of medical devices grew from $6.24 billion in 2020-21 to $8.54 billion in the year 2021-22.

Out of this, implants reported the highest growth in imports, from $ 225.63 million in 2020-21 to $423.06 million in the year 2021-22. The highest imports continue to be in electronics equipment, at $5.44 billion as compared to $3.57 billion, with an increase of 52 per cent.

Surgical instruments reported a 63.12 per cent growth in the year 2021-22 at $169.02 million, as compared to $103.62 million during the previous fiscal year. The imports of consumables and disposables stood at $1.62 billion during the year, with a growth of 10.4 per cent as against $1.47 billion during the same period of previous fiscal year.

IVD reagents reported a growth of 1.23 per cent in imports, at $882.65 million as compared to $871.89 million during the same period last year.

It may be noted that the Association of Indian Medical Device Industry (AiMeD) has last month raised alarm against the higher imports of medical devices, leaving the country to have 12-15 per cent of disability factor in manufacturing of medical devices.

The higher imports has resulted in local industry players – especially those which went into production of masks, PPE kits, thermometers and gloves during the Covid-19 period which helped the country to have adequate supply even during the peak period of the pandemic – shutting shop.

Rajiv Nath, forum coordinator, AiMeD in July said, “NITI Aayog and the Department of Pharmaceuticals recognises that Indian manufacturers have a 12-15 per cent disability factor in manufacturing medical devices in India. We urge the government to neutralise this disability for reduction of medical devices imports in India as was in the case of consumer electronics, including mobile phones and even in the toy industry.”

The minister of state in the ministry of chemicals and fertilisers, Bhagwanth Khuba, said that the Department of Pharmaceuticals implements the Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical devices with a financial outlay of Rs. 3,420 crore and with tenure from FY 2020-21 to FY 2027-28.

Under this scheme, financial incentives will be given to selected companies at the rate of 5% of incremental sales of medical devices manufactured in India and covered under the four target segments of the scheme, for a period of five (5) years. Under the scheme, under two rounds of inviting applications, a total of 42 applications have been received including MSMEs and large manufacturers

“There is no proposal of separate PLI scheme for MSMEs and large manufacturers in medical devices, as the current PLI scheme does not restrict participation of MSMEs,” said the minister in a reply in the Lok Sabha.

So far, 21 applicants are selected under the scheme and this includes 10 MSMEs and 11 large manufacturers. As per the proposals submitted by these applicants, the projects selected under PLI scheme are expected to generate employment opportunities of around 6,411 persons in the tenure of FY 2021-22 to FY 2027-28, he added.

The Ministry of MSME provides credit support to eligible MSME industrial units, including those in the Medical Devices Sector, through schemes such as Credit Guarantee Fund Trust for Micro and Small Enterprises (CGTMSE), Fund of Funds, etc., said the minister.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 108 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 132 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt